Ken Kunisaki is a Respiratory physician affiliated with University of Minnesota. OpenAlex indexes 206 publications with 4,082 citations (h-index 31); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Veterans Dr
Pulmonary 111n
Minneapolis, MN 554172309
Telephone
612-467-4400Registry record last updated 13 Jul 2007.
Clinical trials
- Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults
Sponsor: Seattle Institute for Biomedical and Clinical Research
- Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Sponsor: University of Minnesota
- Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients
Sponsor: Minneapolis Veterans Affairs Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20253 payments
- Allergan, Inc.Program year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2009–2021 per NIH RePORTER. The latest:
- Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease
University of Minnesota
FY2021$667,118R01HL140971 - Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease
University of Minnesota
FY2020$667,118R01HL140971 - Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease
University of Minnesota
FY2019$671,673R01HL140971
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study
Journal of the American Heart Association
2024 - Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
Annals of Internal Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Douglas Yee, MD
University of Minnesota
Charles Herzog, MD
University of Minnesota
Vicki Morrison, MD
University of Minnesota
Patrick Nachman, MD
University of Minnesota
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”